Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenfang Zhou

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Asian Journal of Surgery|October 11, 2021
A case of rapidly progressive Creutzfeldt-Jakob diseasePingyu Tao, Binjia Jiang, Fenfang Zhou
Indian Journal of Pathology & Microbiology|March 24, 2018
Sporadic lymphangioleiomyomatosis with multiple atypical features: A case report and literature reviewXiaokang Wang, Fei Su, Fenfang Zhou, et al.
Human Mutation|May 14, 2026
Decoding Pathogenic Mutational Landscapes in Alzheimer's Disease Through Integrated TranscriptomicsWan Ma, Fenfang Zhou, Huaying Cai, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2022
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axisYongwen Luo, Zhiwen He, Wei Liu, et al.
Cell Death & Disease|February 25, 2023
NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activationPeng Zhang, Liang Chen, Fenfang Zhou, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2023
Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinomaDanwen Wang, Zhao Deng, Mengxin Lu, et al.
International Journal of Surgery Case Reports|March 16, 2026
Primary pulmonary meningioma: a case report and literature reviewDilare Aximu, Lingze Hu, Qianqian Yang, et al.
Academic Radiology|February 27, 2026
Feasibility of Half-Dose Gadoxetic Acid-Enhanced Liver MRI at 5.0 T: A Prospective Intrapatient Comparison with Full-Dose 3.0 TYuannan Hu, Rufang Liao, Liejun Mei, et al.
Cell Death Discovery|May 6, 2026
FBXL6 promotes bladder cancer progression by stabilizing ENO1 through K63-linked ubiquitinationRuoyu Huang, Jingtian Yu, Renran Bai, et al.
Oncology Letters|September 14, 2019
Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysisJun Yu, Yang Xie, Mengying Li, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Asian Journal of Surgery|October 11, 2021
A case of rapidly progressive Creutzfeldt-Jakob diseasePingyu Tao, Binjia Jiang, Fenfang Zhou
Indian Journal of Pathology & Microbiology|March 24, 2018
Sporadic lymphangioleiomyomatosis with multiple atypical features: A case report and literature reviewXiaokang Wang, Fei Su, Fenfang Zhou, et al.
Human Mutation|May 14, 2026
Decoding Pathogenic Mutational Landscapes in Alzheimer's Disease Through Integrated TranscriptomicsWan Ma, Fenfang Zhou, Huaying Cai, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2022
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axisYongwen Luo, Zhiwen He, Wei Liu, et al.
Cell Death & Disease|February 25, 2023
NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activationPeng Zhang, Liang Chen, Fenfang Zhou, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2023
Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinomaDanwen Wang, Zhao Deng, Mengxin Lu, et al.
International Journal of Surgery Case Reports|March 16, 2026
Primary pulmonary meningioma: a case report and literature reviewDilare Aximu, Lingze Hu, Qianqian Yang, et al.
Academic Radiology|February 27, 2026
Feasibility of Half-Dose Gadoxetic Acid-Enhanced Liver MRI at 5.0 T: A Prospective Intrapatient Comparison with Full-Dose 3.0 TYuannan Hu, Rufang Liao, Liejun Mei, et al.
Cell Death Discovery|May 6, 2026
FBXL6 promotes bladder cancer progression by stabilizing ENO1 through K63-linked ubiquitinationRuoyu Huang, Jingtian Yu, Renran Bai, et al.
Oncology Letters|September 14, 2019
Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysisJun Yu, Yang Xie, Mengying Li, et al.
Pageof 4